Meir Cohen-Kashi

Nehora Photonics Ltd. develops optical algorithm technology. The firm develops technology that allows non-invasive continuous monitoring of Hematocrit based on an optical technology. Hematocrit represents the proportion of the blood that consists of packed red blood cells and gives an indication of the body’s hemodynamic. The company was founded by Meir Cohen-Kashi, Eliahu Pewzner, Assaf Deutsch, Ariel Navon, Ofer Barnea and Aharon Shapira in 2008 and is headquartered in Ofakim, Israel.

CritiSense Ltd. develops technology for real-time monitoring of the metabolic state of the patient. Its patient monitoring system provides real-time continuous information via four physiological parameters sensed at the tissue level reflecting the patient’s systemic metabolic state. The company was founded by Avraham Mayevsky in 2004 and is headquartered in Giv'at Shmuel, Israel.